(Q45197531)

10 December 2017

title

Immunogenicity and protective efficacy of virosome based vaccines against Newcastle disease (English)

1 reference

10 December 2017

Rajinder Singh

1

1 reference

10 December 2017

Prem C Verma

series ordinal

2

1 reference

10 December 2017

Satparkash Singh

series ordinal

3

1 reference

10 December 2017

publication date

2 September 2009

1 reference

Tropical Animal Health and Production

10 December 2017

published in

1 reference

10 December 2017

volume

42

1 reference

10 December 2017

issue

3

1 reference

10 December 2017

page(s)

465-471

1 reference

Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge

10 December 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11250-009-9444-2

Mucosal antibody response induced with a nasal virosome-based influenza vaccine.

21 January 2018

1 reference

12 December 2020

Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells

1 reference

12 December 2020

Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes

1 reference

12 December 2020

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 December 2020

Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

1 reference

12 December 2020

Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66.

1 reference

12 December 2020

Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus

1 reference

12 December 2020

Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes).

1 reference

12 December 2020

Investigation of problems associated with intramuscular breast injection of oil-adjuvanted killed vaccines in chickens.

1 reference

12 December 2020

Presence of viral antigens and antibody in the trachea of chickens infected with avian infectious bronchitis virus

1 reference

12 December 2020

The influence of antigen organization on B cell responsiveness

1 reference

12 December 2020

Engineered liposomes and virosomes for delivery of macromolecules

1 reference

12 December 2020

Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Ne

1 reference

12 December 2020

Influenza vaccines: the virosome concept

1 reference

12 December 2020

Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge

1 reference

12 December 2020

Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients.

1 reference

12 December 2020

Reconstituted Sendai virus envelopes as biological carriers: dual role of F protein in binding and fusion with liver cells

1 reference

12 December 2020

Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines

1 reference

12 December 2020

Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity

1 reference

12 December 2020

Protective immunity against Newcastle disease: the role of cell-mediated immunity

1 reference

12 December 2020

The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity

1 reference

12 December 2020

Secondary in vitro stimulation of specific cytotoxic cells to Newcastle disease virus in chickens

1 reference

12 December 2020

Gordon Memorial Lecture. Newcastle disease

1 reference

12 December 2020

Development of a Virosome Vaccine for Newcastle Disease Virus

1 reference

12 December 2020

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

12 December 2020

Newcastle disease virus: an evolving pathogen?

1 reference

12 December 2020

Virosome and ISCOM vaccines against Newcastle disease: preparation, characterization and immunogenicity

1 reference

12 December 2020

Epaxal: a virosomal vaccine to prevent hepatitis A infection

1 reference

12 December 2020

A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs

1 reference

12 December 2020

Local pathological reactions and immune response of chickens to ISA-70 and other adjuvants containing Newcastle disease virus antigen.

1 reference

12 December 2020

Newcastle disease virus: macromolecules and opportunities

1 reference

12 December 2020

Correlation of haemagglutinin-neuraminidase and fusion protein content with protective antibody response after immunisation with inactivated Newcastle disease vaccines

1 reference

12 December 2020

Serology-based potency test for inactivated Newcastle disease vaccines

1 reference

12 December 2020

Proteins of Newcastle disease virus envelope: interaction between the outer hemagglutinin-neuraminidase glycoprotein and the inner non-glycosylated matrix protein

1 reference

12 December 2020

10.1007/S11250-009-9444-2

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

1033037393

0 references

1 reference